Newsroom The latest news from the Pierre Fabre Group. Page inner navigation PRESS RELEASES NEWS PUBLICATIONS Press releases Filter Year Year202520242023202220212020 Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Écrit le Min Max Appliquer Press release Global study on rosacea: 5% of the population affected, according to Pierre Fabre Laboratories. 29 March 2024 Press release Pierre Fabre Laboratories presents the first global study on the “epidemiology of acne” 19 March 2024 Press release Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories 5 March 2024 Load more News Filter Year Year202520242023202220212020 Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Tags (field_news_tags) - Any -#CRCawarenessDuoDayE-SANTÉEngagementHappy New YearLittle Big DreamsInternational Men's Day#OurBreastJourneyCOLLECTION PIERRE FABREConsortiumSustainable developmentDIGITALEADVESMOThe Gustave Roussy PrizeLettre OuverteLymphomaMedicalInnovationMedicalScienceLiaisonMelanomaMSLPink OctoberOncologyANNUAL REPORTStudyEventsPierre Fabre FoundationInnovationNominationsPartnershipsAwardsStrategyTalents Écrit le Min Max Appliquer Sustainable development Partnerships Pierre Fabre Australia: Going on a Green Mission to save our plants. #RBGSydney 24 January 2020 Publications Aucun résultat
Press release Global study on rosacea: 5% of the population affected, according to Pierre Fabre Laboratories. 29 March 2024
Press release Pierre Fabre Laboratories presents the first global study on the “epidemiology of acne” 19 March 2024
Press release Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories 5 March 2024
Sustainable development Partnerships Pierre Fabre Australia: Going on a Green Mission to save our plants. #RBGSydney 24 January 2020
